These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Design, Synthesis, biological Evaluation, and molecular docking studies of novel Pyrazolo[3,4-d]Pyrimidine derivative scaffolds as potent EGFR inhibitors and cell apoptosis inducers. Sherbiny FF; Bayoumi AH; El-Morsy AM; Sobhy M; Hagras M Bioorg Chem; 2021 Nov; 116():105325. PubMed ID: 34507234 [TBL] [Abstract][Full Text] [Related]
7. Design and Synthesis of Non-Covalent Imidazo[1,2- Kumar M; Joshi G; Arora S; Singh T; Biswas S; Sharma N; Bhat ZR; Tikoo K; Singh S; Kumar R Molecules; 2021 Mar; 26(5):. PubMed ID: 33803355 [TBL] [Abstract][Full Text] [Related]
8. Exploration of thiazolidine-2,4-diones as tyrosine kinase inhibitors: Design, synthesis, ADMET, docking, and antiproliferative evaluations. Aziz NAAM; George RF; El-Adl K; Mahmoud WR Arch Pharm (Weinheim); 2023 Mar; 356(3):e2200465. PubMed ID: 36403198 [TBL] [Abstract][Full Text] [Related]
9. Design, Synthesis, and Antiproliferative Activity of New 5-Chloro-indole-2-carboxylate and Pyrrolo[3,4- Al-Wahaibi LH; Mohammed AF; Abdelrahman MH; Trembleau L; Youssif BGM Molecules; 2023 Jan; 28(3):. PubMed ID: 36770936 [TBL] [Abstract][Full Text] [Related]
10. Recruitment of hexahydroquinoline as anticancer scaffold targeting inhibition of wild and mutants EGFR (EGFR Abo Al-Hamd MG; Tawfik HO; Abdullah O; Yamaguchi K; Sugiura M; Mehany ABM; El-Hamamsy MH; El-Moselhy TF J Enzyme Inhib Med Chem; 2023 Dec; 38(1):2241674. PubMed ID: 37548154 [TBL] [Abstract][Full Text] [Related]
11. Computational Design, Synthesis, and Bioevaluation of 2-(Pyrimidin-4-yl)oxazole-4-carboxamide Derivatives: Dual Inhibition of EGFR Raghunath Khedkar N; Sindkhedkar M; Joseph A Bioorg Chem; 2024 Feb; 143():107027. PubMed ID: 38096682 [TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, apoptotic, and antiproliferative effects of 5-chloro-3- (2-methoxyvinyl)-indole-2-carboxamides and pyrido[3,4-b]indol-1-ones as potent EGFR Al-Wahaibi LH; Mohammed AF; Abdel Rahman FES; Abdelrahman MH; Gu X; Trembleau L; Youssif BGM J Enzyme Inhib Med Chem; 2023 Dec; 38(1):2218602. PubMed ID: 37254958 [TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and biological evaluation of novel heptamethine cyanine dye-erlotinib conjugates as antitumor agents. Yang X; Hou Z; Wang D; Mou Y; Guo C Bioorg Med Chem Lett; 2020 Dec; 30(23):127557. PubMed ID: 32949719 [TBL] [Abstract][Full Text] [Related]
14. Novel 2-(5-Aryl-4,5-Dihydropyrazol-1-yl)thiazol-4-One as EGFR Inhibitors: Synthesis, Biological Assessment and Molecular Docking Insights. Al-Warhi T; El Kerdawy AM; Said MA; Albohy A; Elsayed ZM; Aljaeed N; Elkaeed EB; Eldehna WM; Abdel-Aziz HA; Abdelmoaz MA Drug Des Devel Ther; 2022; 16():1457-1471. PubMed ID: 35607598 [TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and biological evaluation of new series of hexahydroquinoline and fused quinoline derivatives as potent inhibitors of wild-type EGFR and mutant EGFR (L858R and T790M). Shaheen MA; El-Emam AA; El-Gohary NS Bioorg Chem; 2020 Dec; 105():104274. PubMed ID: 33339080 [TBL] [Abstract][Full Text] [Related]
16. Discovery of new 1 Gaber AA; Sobhy M; Turky A; Abdulwahab HG; Al-Karmalawy AA; Elhendawy MA; Radwan MM; Elkaeed EB; Ibrahim IM; Elzahabi HSA; Eissa IH J Enzyme Inhib Med Chem; 2022 Dec; 37(1):2283-2303. PubMed ID: 36000168 [TBL] [Abstract][Full Text] [Related]
17. Effective degradation of EGFR Qu X; Liu H; Song X; Sun N; Zhong H; Qiu X; Yang X; Jiang B Eur J Med Chem; 2021 Jun; 218():113328. PubMed ID: 33773286 [TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and anticancer evaluation of thieno[2,3-d]pyrimidine derivatives as dual EGFR/HER2 inhibitors and apoptosis inducers. Elmetwally SA; Saied KF; Eissa IH; Elkaeed EB Bioorg Chem; 2019 Jul; 88():102944. PubMed ID: 31051400 [TBL] [Abstract][Full Text] [Related]
19. Development of Novel Class of Phenylpyrazolo[3,4- Aljohani AKB; El Zaloa WAZ; Alswah M; Seleem MA; Elsebaei MM; Bayoumi AH; El-Morsy AM; Almaghrabi M; Awaji AA; Hammad A; Alsulaimany M; Ahmed HEA Int J Mol Sci; 2023 Oct; 24(19):. PubMed ID: 37834474 [TBL] [Abstract][Full Text] [Related]